| | | kdII posed a good question to Pete and got a good answer from him as noted in the Q&A on Alan Ross' SeekingAlpha PVCT article.
kdII ..... "Still amazes me, after months of dd, how PV-10 isn't even mentioned in the recent Anderson article on promising melanoma treatments (see attachment). Can anyone explain why not? Incredible.
http://bit.ly/1kG0uaI "
"Wrote PVCT CFO; his response to my inquiry above:
Hi Kenneth, this is an easy one. MD Anderson is talking about approved drugs only. Notice, however, that they say there is a lot of work to do. They are very excited about PV-10, like Moffitt, because they realize that even though progress has been made with the approved drugs for melanoma, there is a lot of work to do. That's where PV-10 comes in. PV-10 works before surgery, after surgery, and with and without other agents.
So, expect a lot more positive things to be said about PV-10, including from MD Anderson. Also, notice the publication on our website already about PV-10 from MD Anderson! They realize how important PV-10 is, but again, they are just addressing approved drugs in the article you reference.
Thanks, Pete
Peter Culpepper, CFO, COO" |
|
